The U.S. drug regulator approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in premenopausal women.
Danaher Corp. said it would buy medical diagnostics company Cepheid in a deal valued at $4 billion that will strengthen its presence in molecular diagnostics.
Valeant Pharmaceuticals International Inc will cut its sales force for Addyi, a treatment aimed at female sexual dysfunction, as well as some employees who sell dermatology products, according to an […]
Remember when the FDA rejected drugs? We just got treated to a whole lot of drama this week as to whether Addyi, a drug to boost women’s libidos, would be […]
Sprout Pharmaceuticals continues to remain atop the news cycles just days after the U.S. Food and Drug Administration (FDA) approved the first female sex-drive drug, Addyi. Today Canadian-based Valeant Pharma […]
The FDA has approved a controversial drug designed to enhance a woman’s sexual drive. Addyi (generic name: flibanserin), from Sprout Pharmaceuticals, acts in the brain to enhance a woman’s libido. […]
